Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Apr
25
2023
Chinese Utility Model Grants Down Over 21% in 2023 Q1 YoY; Trademark Grants Down Almost 53% Schwegman, Lundberg & Woessner, P.A.
May
10
2023
China’s National Intellectual Property Administration Revokes Licenses of 5 Patent Firms for Filing Over 30,000 Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
May
17
2013
SAP Files Ex Parte Reexamination Request for Patent Review using Prior Art from Ongoing Litigations Schwegman, Lundberg & Woessner, P.A.
Jun
13
2013
Supreme Court Rules In Myriad On Patentability Of DNA Schwegman, Lundberg & Woessner, P.A.
Sep
28
2023
China’s Cyberspace Administration Proposes Loosening Restrictions on Cross-Border Data Flows Schwegman, Lundberg & Woessner, P.A.
Sep
20
2013
“Patent Assertion and Startup Innovation": Some Sensible Ideas Schwegman, Lundberg & Woessner, P.A.
Oct
14
2013
Parties Terminate Covered Business Method (CBM) Before They Settle Dispute to Avoid Patent Trial and Appeal Board (PTAB) Decision Schwegman, Lundberg & Woessner, P.A.
May
24
2019
Claims of Uniloc Patents Covering a Software Distribution System Found Patent Eligible by Federal Circuit Schwegman, Lundberg & Woessner, P.A.
Nov
20
2023
U.S.-China Economic and Security Review Commission Releases 2023 Report to Congress Schwegman, Lundberg & Woessner, P.A.
Jul
16
2019
Wide-Ranging Senate Bill Aims to Streamline Post-Grant Proceedings and Block Trolls Schwegman, Lundberg & Woessner, P.A.
Dec
26
2023
China’s National Intellectual Property Administration Releases Amended Patent Examination Guidelines – Introduces Inventiveness Examination of Utility Models Schwegman, Lundberg & Woessner, P.A.
Jan
23
2014
SAP’s Cert Petition Denied by Supreme Court in Versata Patent Infringement Suit Schwegman, Lundberg & Woessner, P.A.
Mar
3
2014
GlaxoSmithKline v. Banner Pharmacaps – Written Description Requirement 101 Schwegman, Lundberg & Woessner, P.A.
Mar
27
2024
China’s National Intellectual Property Administration Releases 2024 Budget Schwegman, Lundberg & Woessner, P.A.
Apr
24
2024
Shanghai to Subsidize Construction of Standard Essential Patent Pools Schwegman, Lundberg & Woessner, P.A.
Jan
3
2020
Shenzhen Court Rules AI-Generated Articles are Entitled to Copyright Protection Schwegman, Lundberg & Woessner, P.A.
Apr
24
2014
Eastern District of Texas Denies SAP’s Motion to Vacate the Judgment in the Versata Patent Infringement Case Schwegman, Lundberg & Woessner, P.A.
Jan
31
2020
China Patent Office to Cease Issuing Paper Patent Certificates Schwegman, Lundberg & Woessner, P.A.
May
9
2014
Dolly Led to Slaughter – Part II - Adult Cell Cloning Schwegman, Lundberg & Woessner, P.A.
Mar
8
2020
Chinese Trademark Office Announces Rejections of Malicious Epidemic-Related Trademark Applications Schwegman, Lundberg & Woessner, P.A.
Mar
12
2020
Samsung v. Prisua – Fed. Cir. Tries to Eliminate IPR Catch-22 Schwegman, Lundberg & Woessner, P.A.
Apr
20
2020
CardioNet v. Infobionics: The Requirement for Improvements in Patent Eligibility Schwegman, Lundberg & Woessner, P.A.
Jun
19
2014
Alice v. CLS Bank: Supreme Court Continues to Grope in Dark for Contours of Abstract Idea Exception Schwegman, Lundberg & Woessner, P.A.
May
4
2020
China Releases Draft Amended Copyright Law With Punitive Damages and Digital Rights Management Articles Schwegman, Lundberg & Woessner, P.A.
Jun
3
2020
Chinese Patent Application for Coronavirus Vaccine Published Schwegman, Lundberg & Woessner, P.A.
Oct
31
2016
Chisum and Mueller Dissect The Recent En Banc Decision In Apple v Samsung – “Smartphone Wars: Federal Circuit Shenanigans?” Schwegman, Lundberg & Woessner, P.A.
Jun
11
2020
The China National Intellectual Property Administration Aims to Speed Up Patent Prosecution Schwegman, Lundberg & Woessner, P.A.
Jul
20
2020
80 Million RMB Awarded in China Melamine Patent Litigation Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins